bgp-15
Small moleculeexperimental
Clinical trial activity
1 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01069965)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
N=C(NOCC(O)CN1CCCCC1)c1cccnc1- Mol. weight
- 278.36 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4747845 ↗
Also known as
- bgp 15
- bgp-15
- bgp-15
- bgp-15
- o-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01069965 | Phase 2 | Oct 1, 2010 | Barc NV, Drug Research Center, Balatonfured, Hungary, Georgetown University, Integrium, Kinexum LLC, Msource Medical Development GmbH, N-Gene Research Laboratories, Inc., Thermo Fisher Scientific, University of Cologne |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Barc NV | For profit | 1 | 0 | 1 | 2010 |
| Drug Research Center, Balatonfured, Hungary | For profit | 1 | 0 | 1 | 2010 |
| Georgetown University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Integrium | For profit | 1 | 0 | 1 | 2010 |
| Kinexum LLC | For profit | 1 | 0 | 1 | 2010 |
| Msource Medical Development GmbH | For profit | 1 | 0 | 1 | 2010 |
| N-Gene Research Laboratories, Inc. | For profit | 1 | 1 | 1 | 2010 |
| Thermo Fisher Scientific | For profit | 1 | 0 | 1 | 2010 |
| University of Cologne | Academic/Hospital | 1 | 0 | 1 | 2010 |
9 organizations
Page 1 / 1